WPI wins NIH grant to study components of a potentially potent, low-cost malaria treatment

(Worcester Polytechnic Institute) With a three-year, $420,000 award from the National Institutes of Health, a team of researchers at Worcester Polytechnic Institute, led by Pamela Weathers, PhD, will test a plant-based therapy it is developing that consists of dried leaves from the sweet wormwood plant, Artemisia annua. The therapy may prove to be a highly effective and low-cost treatment for malaria, one of the world's most prevalent and deadly infectious diseases.
Source: EurekAlert! - Biology - Category: Biology Source Type: news

Related Links:

A study of 62 seriously ill coronavirus patients in Renmin Hospital, Wuhan, found that giving them hydroxychloroquine healed their fevers and coughs faster than standard treatment.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
A group of moderately ill people were given hydroxychloroquine, which appeared to ease their symptoms quickly, but more research is needed.
Source: NYT - Category: American Health Authors: Tags: Coronavirus (2019-nCoV) Hydroxychloroquine (Drug) Drugs (Pharmaceuticals) Quarantines Shortages Autoimmune Diseases Pneumonia Immune System Malaria Schaffner, William your-feed-healthcare Source Type: news
Matthew FeeneyDeadly misinformation spread across social media long before COVID-19 emerged, but amid the ongoing pandemic attempts to tackle such content are once again in the limelight. These efforts provide an opportunity for classical liberals to emphasize the importance of freedom of association and to prepare for discussions about how private institutions handle misinformation amid a  crisis.Too often we think of the freedom of speech to be a  freedom that protects speakers from government censorship. And while the freedom to speak is a necessary condition for a functioning liberal society it&rsqu...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
Conditions:   Plasmodium Falciparum Infection;   Malaria Interventions:   Biological: VRC-MALMAB0100-00-AB (CIS43LS);   Other: Normal saline Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Malaria Research and Training Center; Faculté de Médecine Pharmacie d'Odontostomatologie; University of Sciences, Techniques,&Technologies of Bamako (USTTB);   Vaccine Research Center;   University of Washington;   Harvard School of Public Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
April 1 (Reuters)—The U.S. Food and Drug Administration (FDA) said malaria drugs hydroxychloroquine and related chloroquine are in shortage due to a surge in demand because of the coronavirus pandemic. The drugs, which have been tried with some success to treat the illness caused by the virus, were added to the agency’s website that lists... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Drug Updates Drug shortage FDA HCQ Hydroxychloroquine (HCQ) U.S. Food and Drug Administration (FDA) Source Type: research
[Daily Maverick] While the promise of repositioning 'old' drugs such as chloroquine and hydroxychloroquine is tantalising, it is critical that the hazards of using unapproved treatments are shared with the public to prevent needless fatalities and supply shortages that may further burden already strained healthcare systems.
Source: AllAfrica News: Malaria - Category: Infectious Diseases Source Type: news
Drug maker Amneal is donating 400,000 doses of hydroxychloroquine to Louisiana in the hopes of helping the state fight coronavirus, which has struck more than 4,000 people there, killing 185.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
[Premium Times] 12 former African leaders, including former Nigerian president, Olusegun Obasanjo, have called for an emergency plan to combat the COVID-19 onslaught in Africa at a continental or regional level.
Source: AllAfrica News: Malaria - Category: Infectious Diseases Source Type: news
TUESDAY, March 31, 2020 -- With little evidence that the malaria drugs hydroxychloroquine and chloroquine can prevent or treat COVID-19, the U.S. Food and Drug Administration has given emergency approval to distribute millions of doses of the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Condition:   Malaria (Plasmodium Falciparum) Interventions:   Drug: Meplazumab for Injection;   Drug: Sterile normal saline (0.9%) Sponsor:   Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biology | Grants | Health | Infectious Diseases | Malaria | National Institutes of Health (NIH) | Study | Wormwood